BioPharma Clinical Trials
Innovent's IBI311 Clears Phase 3 Hurdle for Thyroid Eye Disease with Promising Results
The trial also successfully met its key secondary endpoints, including the overall response rate, the percentage of subjects achieving a clinical activity ...
February 20, 2024 | News
Japan Accelerates Approval Process for Groundbreaking Urothelial Cancer Treatment by Astellas
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that Japan's Ministry of Health, Labour a...
February 19, 2024 | News
Jacobio Gains China CDE Approval for Phase III SHP2 and KRAS G12C Inhibitor Trial
This approved study in China is a randomized active controlled phase III trial design to evaluate the efficacy and safety of JAB-3312 in combinat...
February 19, 2024 | News
FDA Prioritizes Review of Bristol Myers Squibb's Augtyro™ for NTRK-Positive Solid Tumors
Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for A...
February 15, 2024 | News
BioAge Secures $170 Million in Series D Funding to Propel Obesity and Metabolic Disease Drug Development
BioAge Labs (“BioAge”), a pioneering biotechnology firm dedicated to advancing novel treatments for obesity and metabolic diseases by e...
February 14, 2024 | News
Brii Biosciences Secures Intellectual Property Rights for HBV Treatment from VBI Vaccines
Brii Biosciences Limited ("Brii Bio"), a leader in developing innovative treatments for diseases with significant unmet needs, has announced a strategic ac...
February 14, 2024 | News
Otsuka's AVP-786 Falls Short in Phase 3 Trial for Alzheimer's Agitation
Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC) and its parent company Otsuka Pharmaceutical, Co. Ltd. (Otsuka) have released the t...
February 13, 2024 | News
Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay Therapeutics
Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...
February 13, 2024 | News
CSL Reveals Phase 3 AEGIS-II Trial Results for CSL112
"We look forward to sharing our scientific learnings regarding cholesterol efflux and recurrent cardiovascular events," said C. Michael Gibson, M.S., ...
February 12, 2024 | News
Zymedi initiates first human dosing of ZMA001 in a clinical trial for Pulmonary Arterial Hypertension in South Korea
In collaboration with the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), Zymedi is conducting this t...
February 09, 2024 | News
SMC Laboratories Unveils STAM™-HCC/IO+ Mouse for Advancing Liver Cancer Drug Development in Immuno-Oncology
The company specializes in liver-related services and has evaluated test substances in over 15 MOA categories as well as over 270 target molecules us...
February 07, 2024 | News
ShiraTronics finishes Australian pilot study enrollment, gears up for pivotal clinical trial
Migraine, recognized globally as a significant cause of disability, particularly among pre-menopausal women, poses a substantial health challenge. For arou...
February 07, 2024 | News
Stakeholders Rally for Sustainable Funding to Secure Australia's Future of National One Stop Shop for Clinical Trials
The NOSS, a pioneering digital platform, seeks to streamline the approval and reporting procedures for human research, particularly clinical trials, in Aus...
February 06, 2024 | News
Genesis MedTech Finishes U.S. Study Enrollment for J-Valve™ in Severe Aortic Regurgitation
Genesis MedTech, a leading medical device company, today announced the completion of enrollment in its United States Early Feasibility Study (EFS) usi...
February 06, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
